Altered cholesterol synthesis as a mechanism involved in methyl isobutyl ketone-potentiated experimental cholestasis
- PMID: 9439723
- DOI: 10.1006/taap.1997.8274
Altered cholesterol synthesis as a mechanism involved in methyl isobutyl ketone-potentiated experimental cholestasis
Abstract
Mechanisms by which ketones potentiate manganese-bilirubin (Mn-BR)-induced cholestasis are unknown. The purpose of the present study was to investigate the effect of methyl isobutyl ketone (MiBK), a widely used ketonic solvent, at the level of the bile canalicular membrane (BCM) and to verify if altered membrane lipid dynamics could be involved in MiBK-potentiated Mn-BR cholestasis. Male Sprague-Dawley rats were exposed 4 hr/day for 3 days to MiBK vapors (200 or 600 ppm). Eighteen hours after the last exposure, manganese (Mn, 4.5 mg/kg) was given i.v. followed 15 min later by bilirubin (BR, 25 mg/kg). Rats were killed 30 min after BR; liver cell plasma membranes (bile canalicular and sinusoidal), microsomes, mitochondria, and cytosol were isolated by differential centrifugation. Lipids were extracted and cholesterol was measured in each fraction. After Mn-BR and MiBK exposure (600 ppm), results indicated a marked increase in BCM cholesterol content compared to rats exposed to air only. This increase was greater than that due to Mn-BR or MiBK given alone. Also, results indicated that cholesterol increased in a dose-related fashion in BCM after MiBK exposure, whereas PM cholesterol remained unaltered. To identify the source of the increased BCM cholesterol and to permit distinction between de novo cholesterol synthesis and subcellular shifts, the hepatic lipid pool was labeled in vivo with [3H]-cholesterol and [2-14C]-mevalonic acid, a cholesterol synthesis precursor. Results showed that after 600 ppm MiBK exposure, 14C-labeled cholesterol was greater than 3H-labeled cholesterol, indicating that the contribution of de novo cholesterol synthesis to the total cholesterol content of the various isolated hepatocellular fractions was more important than the contribution of intracellular pools. Therefore, increased BCM cholesterol content and enhanced accumulation of newly synthesized cholesterol appear to be involved in MiBK potentiation of Mn-BR-induced cholestasis.
Similar articles
-
Manganese-bilirubin effect on cholesterol accumulation in rat bile canalicular membranes.Toxicol Sci. 2000 Jan;53(1):150-5. doi: 10.1093/toxsci/53.1.150. Toxicol Sci. 2000. PMID: 10653533
-
Ketone potentiation of intrahepatic cholestasis: effect of two aliphatic isomers.J Toxicol Environ Health. 1997 Jan;50(1):41-52. J Toxicol Environ Health. 1997. PMID: 9015131
-
Potentiation by methyl isobutyl ketone of the cholestasis induced in rats by a manganese-bilirubin combination or manganese alone.Toxicol Appl Pharmacol. 1987 Dec;91(3):477-83. doi: 10.1016/0041-008x(87)90069-x. Toxicol Appl Pharmacol. 1987. PMID: 3424376
-
Safety assessment of MIBK (methyl isobutyl ketone).Int J Toxicol. 2004;23 Suppl 1:29-57. doi: 10.1080/10915810490274298. Int J Toxicol. 2004. PMID: 15162837 Review.
-
Neurotoxic interactions of industrially used ketones.Neurotoxicology. 2000 Jun;21(3):409-18. Neurotoxicology. 2000. PMID: 10894131 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials